Parametric Portfolio Associates’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.87M Sell
67,918
-10,011
-13% -$286K ﹤0.01% 2456
2021
Q4
$3.21M Buy
77,929
+8,513
+12% +$376K ﹤0.01% 2151
2021
Q3
$3.22M Sell
69,416
-3,815
-5% -$166K ﹤0.01% 2133
2021
Q2
$2.93M Sell
73,231
-25,935
-26% -$1.11M ﹤0.01% 2201
2021
Q1
$5.33M Sell
99,166
-16,483
-14% -$949K ﹤0.01% 2118
2020
Q4
$5.66M Sell
115,649
-6,000
-5% -$278K ﹤0.01% 1988
2020
Q3
$3.95M Sell
121,649
-6,179
-5% -$196K ﹤0.01% 2058
2020
Q2
$3.31M Buy
127,828
+333
+0.3% +$8.3K ﹤0.01% 2169
2020
Q1
$3.1M Sell
127,495
-46,270
-27% -$1.16M ﹤0.01% 2096
2019
Q4
$4.85M Sell
173,765
-5,935
-3% -$154K ﹤0.01% 2089
2019
Q3
$4.31M Buy
179,700
+6,718
+4% +$179K ﹤0.01% 2121
2019
Q2
$4.93M Buy
172,982
+10,728
+7% +$268K ﹤0.01% 2027
2019
Q1
$4.06M Buy
162,254
+67,867
+72% +$1.3M ﹤0.01% 2145
2018
Q4
$1.19M Buy
+94,387
New +$1.12M ﹤0.01% 2881
2017
Q4
Sell
-87,036
Closed -$763K 3946
2017
Q3
$763K Buy
87,036
+23,461
+37% +$191K ﹤0.01% 3184
2017
Q2
$530K Sell
63,575
-17,570
-22% -$143K ﹤0.01% 3341
2017
Q1
$745K Buy
81,145
+22,966
+39% +$188K ﹤0.01% 3011
2016
Q4
$450K Buy
+58,179
New +$435K ﹤0.01% 3240

Other funds holding VCYT

Parametric Portfolio Associates's VCYT Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Veracyte (VCYT) stake by 13% in Q1 2022, selling an estimated $286K and leaving 67,918 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

Parametric Portfolio Associates first reported a position in VCYT in Q4 2016 and has held it in 18 quarters since. The position peaked at $5.66M in Q4 2020. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.

  • Parametric Portfolio Associates held 67,918 shares of Veracyte worth $1.87M as of Q1 2022.
  • Parametric Portfolio Associates sold 10,011 Veracyte shares in Q1 2022, an estimated $286K.
  • Veracyte made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2456 holding.
  • Parametric Portfolio Associates first reported a position in Veracyte in Q4 2016 and has held it in 18 quarters since.
  • Parametric Portfolio Associates's Veracyte position peaked at $5.66M in Q4 2020.
  • 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.